Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort.
Guillaume LanoAntoine BraconnierStanislas BatailleGuilhem CavailleJulie Moussi-FrancesBertrand GondouinPascal BindiMagued NakhlaJanette MansourPascale HalinBénédicte LevyEric CanivetKhaled GahaIsabelle KazesNatacha NoelAlain WynckelAlexandre DebrumetzNoémie Jourde-ChicheValerie MoalRomain VialViolaine ScarfoglièreMickael BobotMarion GullyTristan LegrisMarion PelletierMarion SalleeStephane BurteyPhilippe BrunetThomas RobertPhilippe RieuPublished in: Clinical kidney journal (2020)
COVID-19 is a severe disease with poor prognosis in patients with ESRD. Usual treatment with ARBs seems to be protective of critical evolution and mortality. There is no evidence of clinical benefit with the combination of AZT/HCQ.